Patents/Assignees

Albunext, LLC

2 patents in portfolio

US12576141utility2026
Albumin Bound Macromolecule Tri-agonist Activating Glp-1/gip/glucagon Receptors
0 cites
US12551541utility2026
Albumin Bound Macromolecule Tri-agonist Activating GLP 1/gip/glucagon Receptors and Methods Therefor
0 cites